1.Determination of % PRA and identification of HLA antibody using home-made lymphocytes panel.
Korean Journal of Blood Transfusion 1992;3(1):71-77
No abstract available.
Lymphocytes*
2.Lymphomatoid Papulosis with Mycobacterium Other Than Tuberculosis.
Dong Ha KIM ; Youn Hak SOHN ; Joong Sun LEE ; Dae Won KOO ; Kyung Eun JUNG
Korean Journal of Dermatology 2016;54(6):496-497
No abstract available.
Lymphomatoid Papulosis*
;
Mycobacterium*
;
Tuberculosis*
3.Lymphomatoid Papulosis with Mycobacterium Other Than Tuberculosis.
Dong Ha KIM ; Youn Hak SOHN ; Joong Sun LEE ; Dae Won KOO ; Kyung Eun JUNG
Korean Journal of Dermatology 2016;54(6):496-497
No abstract available.
Lymphomatoid Papulosis*
;
Mycobacterium*
;
Tuberculosis*
4.H2 Receptor Antagonists and Gastric Cancer in the Elderly: A Nested Case-Control Study.
Yooni KIM ; Dae Seog HEO ; Seung Mi LEE ; Kyoung Eun YOUN ; Hye Won KOO ; Jong Myon BAE ; Byoung Joo PARK
Korean Journal of Preventive Medicine 2002;35(3):245-254
OBJECTIVE: To test if the intake of H2 receptor antagonists (H2-RAs) increases the risk of gastric cancer in the elderly. METHODS: The source population for this study was drawn from the responders to a questionnaire survey administered to the Korea Elderly Pharmacoepidemiological Cohort (KEPEC), who were beneficiaries of the Korean Medical Insurance Corporation, were at least 65 years old, and residing in Busan in 1993. The information on H2-RAs exposure was obtained from a drug prescription database compiled between Jan. 1993 and Dec. 1994. The cases consisted of 76 gastric cancer patients, as confirmed from the KMIC claims data, the National Cancer Registry and the Busan Cancer Registry. The follow-up period was from Jan. 1993 to Dec. 1998. Cancer free controls were randomly selected by 1:4 individual matching, which took in to consideration the year of birth and gender. Information on confounders was collected by a mail questionnaire survey. The odds ratios, and their 95% confidence intervals, were calculated using a conditional logistic regression model. RESULTS: After adjusting for a history of gastric ulcer symptoms, medication history, and body mass index, the adjusted OR (aOR) was 4.6 (95% CI=1.72-12.49). The odds ratio of long term use (more than 7 days) was 2.3 (95% CI=1.07-4.82). The odds ratio of short term use was 4.6 (95% CI=1.26-16.50). The odds ratio of parenteral use was 4.4 (95% CI=1.16-17.05) and combination use between the oral and parenteral routes (aOR, 16.8; 95% CI=1.21-233.24) had the high risk of gastric cancer. The aOR of cimetidine was 1.7 (95% CI=1.04-2.95). The aOR of ranitidine was 2.0 (95% CI=1.21-3.40). The aOR of famotidine was 1.7 (95% CI=0.98-2.80). CONCLUSION: The intake of H2-RAs might increase the risk of gastric cancer through achlorhydria in the elderly.
Achlorhydria
;
Aged*
;
Body Mass Index
;
Busan
;
Case-Control Studies*
;
Cimetidine
;
Cohort Studies
;
Drug Prescriptions
;
Famotidine
;
Follow-Up Studies
;
Humans
;
Insurance
;
Korea
;
Logistic Models
;
Odds Ratio
;
Parturition
;
Pharmacoepidemiology
;
Postal Service
;
Surveys and Questionnaires
;
Ranitidine
;
Stomach Neoplasms*
;
Stomach Ulcer
5.Brain Injuries Due to Neonatal Hypoglycemia: Case Report.
Dae Bong KIM ; Chang joon SONG ; Mae Young CHANG ; Hyae Won YOUN
Journal of the Korean Radiological Society 2003;49(4):359-362
Although hypoglycemia may be common among neonates, brain injuries resulting from isolated neonatal hypoglycemia are rare. The condition may cause neurological symptoms such as stupor, jitteriness, and seizures, though in their absence, diagnosis is delayed or difficult. Hypoglycemia was diagnosed in a three-day-old neonate after he visited the emergency department with loose stool, poor oral intake, and decreased activity, first experienced two days earlier. Two days after his visity, several episodes of seizure occurred. T2 and diffusion-weighted magnetic resonance (MR) scanning, performed at 11 days of age, revealed bilateral and symmetrical high signal intensity lesions in occipital, parietal, and temporal lobes. We report the MR findings of hypoglycemic encephalopathy in a neonate.
Brain Injuries*
;
Brain*
;
Diagnosis
;
Emergency Service, Hospital
;
Humans
;
Hypoglycemia*
;
Infant, Newborn
;
Rabeprazole
;
Seizures
;
Stupor
;
Temporal Lobe
6.Multi-Parametric Quantitative MRI for Measuring Myelin Loss in Hyperglycemia-Induced Hemichorea
Sung Won YOUN ; Oh Dae KWON ; Moon Jung HWANG
Investigative Magnetic Resonance Imaging 2019;23(2):148-156
Hyperglycemia-induced hemichorea (HGHC) is a rare but characteristic hyperkinetic movement disorder involving limbs on one side of the body. In a 75-year-old woman with a left-sided HGHC, conventional brain MR imaging showed very subtle T1-hyperintensity and unique gadolinium enhancement in the basal ganglia contralateral to movements. Multi-parametric MRI was acquired using pulse sequence with quantification of relaxation times and proton density by multi-echo acquisition. Myelin map was reconstructed based on new tissue classification modeling. In this case report of multi-parametric MRI, quantitative measurement of myelin change related to HGHC in brain structures and its possible explanations are presented. This is the first study to demonstrate myelin loss related to hyperglycemic insult in multi-parametric quantitative MR imaging.
Aged
;
Basal Ganglia
;
Brain
;
Classification
;
Extremities
;
Female
;
Gadolinium
;
Humans
;
Hyperglycemia
;
Hyperkinesis
;
Magnetic Resonance Imaging
;
Movement Disorders
;
Myelin Sheath
;
Protons
;
Relaxation
7.Risk Assessment of the Occurrence of Blood Products Infected with Dengue Virus Based on Travelers to the Areas of Dengue Outbreak
Dae Ho KO ; Jae-won KANG ; Jungwon KANG ; Miae YOUN
Korean Journal of Blood Transfusion 2020;31(3):230-238
Background:
Dengue fever is considered one of the transfusion-transmissible emerging infectious diseases. Dengue fever has been reported every year by the Korea Disease Control and Prevention Agency (KDCA). Because a blood donor screening assay to detect the dengue virus (DENV) as an agent of dengue fever is not performed, the risk of transfusion-transmitted DENV infection needs to be assessed.
Methods:
This study collected the data of DENV infected cases from the Infectious Disease Portal of the KDCA, the data of blood donors and blood components from the Blood Information Management System of the Korean Red Cross, and the data of travelers to major dengue outbreak countries from the Korean Tourism Organization.All data were from 2016 to 2018. A risk assessment was performed using European Up-Front Risk Assessment Tool (EUFRAT).
Results:
The risk of DENV-infected red cells and platelet concentrate was higher than that of plasma and apheresis platelet. Nevertheless, the risk of the DENV infected blood component was shown to be less than one case per year for all kinds of blood components.
Conclusion
All the DENV infected cases in Korea were overseas travelers. Therefore, the risk of transfusiontransmissible DENV infection is very low. On the other hand, continuous observation and monitoring are required because Aedes albopictus as a vector of DENV is found in Korea, and the increase in reported cases may lead to domestic infections.
8.Risk Assessment of the Occurrence of Blood Products Infected with Dengue Virus Based on Travelers to the Areas of Dengue Outbreak
Dae Ho KO ; Jae-won KANG ; Jungwon KANG ; Miae YOUN
Korean Journal of Blood Transfusion 2020;31(3):230-238
Background:
Dengue fever is considered one of the transfusion-transmissible emerging infectious diseases. Dengue fever has been reported every year by the Korea Disease Control and Prevention Agency (KDCA). Because a blood donor screening assay to detect the dengue virus (DENV) as an agent of dengue fever is not performed, the risk of transfusion-transmitted DENV infection needs to be assessed.
Methods:
This study collected the data of DENV infected cases from the Infectious Disease Portal of the KDCA, the data of blood donors and blood components from the Blood Information Management System of the Korean Red Cross, and the data of travelers to major dengue outbreak countries from the Korean Tourism Organization.All data were from 2016 to 2018. A risk assessment was performed using European Up-Front Risk Assessment Tool (EUFRAT).
Results:
The risk of DENV-infected red cells and platelet concentrate was higher than that of plasma and apheresis platelet. Nevertheless, the risk of the DENV infected blood component was shown to be less than one case per year for all kinds of blood components.
Conclusion
All the DENV infected cases in Korea were overseas travelers. Therefore, the risk of transfusiontransmissible DENV infection is very low. On the other hand, continuous observation and monitoring are required because Aedes albopictus as a vector of DENV is found in Korea, and the increase in reported cases may lead to domestic infections.
9.Recent trends in the treatment of chronic hepatitis C.
Dae Won JUN ; Won Young TAK ; Si Hyun BAE ; Youn Jae LEE
The Korean Journal of Hepatology 2012;18(1):22-28
Pegylated interferon and ribavirin combination therapy is accepted as the standard antiviral treatment for chronic hepatitis C regardless of HCV genotype. This combination therapy achieves higher response rates than previous therapy, but, nevertheless, a large proportion of patients suffer from treatment failure or adverse events. Recent clinical studies of viral kinetics during antiviral treatment have led to the introduction of response-guided therapy, the concept of 'customized therapy depending on viral response', which focuses on modulation of the treatment period depending on the viral response to create a sustained viral response without unnecessary medication and costs. New upcoming direct-acting antivirals (DAAs) maximize response rate, and triple therapy including DAAs along with pegylated interferon and ribavirin combination therapy could soon be the standard therapy. In this article, we reviewed the factors affecting treatment, response guided treatment, retreatment after failure of standard treatment, management of adverse events during treatment, and new treatment options.
Anemia, Hemolytic/drug therapy/etiology
;
Antiviral Agents/adverse effects/*therapeutic use
;
Erythropoietin/therapeutic use
;
Hepatitis C, Chronic/*drug therapy
;
Humans
;
Individualized Medicine
;
Interferon-alpha/adverse effects/therapeutic use
;
Polyethylene Glycols/adverse effects/therapeutic use
;
Protease Inhibitors/therapeutic use
;
RNA, Viral/analysis
;
Recombinant Proteins/adverse effects/therapeutic use
;
Ribavirin/adverse effects/therapeutic use
10.Changes in Bone Mineral Density of Both Proximal Femurs after Total Knee Arthroplasty.
Kwang Kyoun KIM ; Ye Yeon WON ; Youn Moo HEO ; Dae Hee LEE ; Jeong Yong YOON ; Won Sub SUNG
Clinics in Orthopedic Surgery 2014;6(1):43-48
BACKGROUND: This study investigated the effects of total knee arthroplasty (TKA) on bone mineral density (BMD) of the proximal femur in patients who underwent the procedure. METHODS: Forty-eight patients scheduled to undergo unilateral TKA because of primary knee osteoarthritis were included in this study, which was conducted at a medical center between October 2006 and October 2009. In these 48 patients, 96 hips were evaluated. Measurement of BMD was performed preoperatively and one month, three months, six months, and one year after unilateral TKA. Repeated measured analysis of variance and paired t-tests for comparison of two repeated samples were used to compare differences between time points (preoperation, one, three, six, and 12 months) and between the operative and nonoperative sides. RESULTS: Preoperatively, BMD of the femoral neck, trochanter, and total hip on the operative side were lower than on the nonoperative side; however, there was no statistical difference. BMD of both femoral neck areas was significantly lower than preoperative BMD at one month and three months after TKA. BMD of both trochanter areas was significantly lower than preoperative BMD at one month and three months after TKA. BMD of both total hips was significantly lower than preoperative BMD at three months after TKA. However, no statistical differences of changes in BMD were observed between the operative and nonoperative sides at each measurement time. CONCLUSIONS: According to our results, TKA was found to affect both proximal femurs during the acute period. However, TKA did not affect a change in BMD of the proximal femur during one year postoperative.
Aged
;
Arthroplasty, Replacement, Knee/*adverse effects
;
Bone Density/*physiology
;
Female
;
Femur Neck/*physiopathology
;
Follow-Up Studies
;
Humans
;
Male
;
Middle Aged